Rezultati pretrage - Doyle, Austin

Secretion of Dopa in Phaeochromocytoma od Louis, William J., Doyle, Austin E., Heath, William C., Robinson, Maxwell J.

Preuzmi cijeli tekst Preuzmi cijeli tekst

LC-MS/MS assay for the quantitation of the ATR kinase inhibitor VX-970 in human plasma od Kiesel, Brian F., Scemama, Jonas, Parise, Robert A., Villaruz, Liza, Iffland, Andre, Doyle, Austin, Ivy, Percy, Chu, Edward, Bakkenist, Christopher J., Beumer, Jan H.

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer od Ahn, Daniel H., Li, Junan, Wei, Lai, Doyle, Austin, Marshall, John L., Schaaf, Larry J., Phelps, Mitch A., Villalona-Calero, Miguel A., Bekaii-Saab, Tanios

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

University of Chicago Phase II Consortium Trial of Selumetinib (MEKi) Demonstrates Low Tolerability and Efficacy in Relapsed DLBCL od Galanina, Natalie, Smith, Sonali M., Liao, Chuanhong, Petrich, Adam, Libao, Bernadette, Gartenhaus, Ronald, Westin, Jason, Cohen, Kenneth S, Knost, James A., Stadler, Walter M., Doyle, Austin, Karrison, Theodore, Gordon, Leo, Evens, Andrew M.

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer od Deming, Dustin A., Cavalcante, Ludmila L., Lubner, Sam J., Mulkerin, Daniel L., LoConte, Noelle K., Eickhoff, Jens C., Kolesar, Jill M., Fioravanti, Suzanne, Greten, Tim F., Compton, Kathryn, Doyle, Austin G., Wilding, George, Duffy, Austin, Liu, Glenn

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors od Ramaswamy, Bhuvaneswari, Phelps, Mitch A., Baiocchi, Robert, Bekaii-Saab, Tanios, Ni, Wenjun, Lai, Ju-Ping, Wolfson, Anna, Lustberg, Mark E, Wei, Lai, Wilkins, Deidre, Campbell, Angela, Arbogast, Daria, Doyle, Austin, Byrd, John C, Grever, Michael R, Shah, Manisha H.

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

NFM-07. SPRINT: PHASE II STUDY OF THE MEK 1/2 INHIBITOR SELUMETINIB (AZD6244, ARRY-142886) IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND INOPERABLE PLEXIFORM NEUROFIBROMAS (P... od Gross, Andrea, Wolters, Pamela, Baldwin, Andrea, Dombi, Eva, Fisher, Michael J, Weiss, Brian, Kim, AeRang, Blakeley, Jaishri, Whitcomb, Patricia, Holmblad, Marielle, Maritin, Staci, Roderick, Marie Claire, Paul, Scott M, Therrien, Janet, Heisey, Kara, Doyle, Austin, Smith, Malcolm, Glod, John, Steinberg, Seth, Widemann, Brigitte C

Preuzmi cijeli tekst Preuzmi cijeli tekst

Phase II, 2-Stage, 2-Arm, PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent Endometrial Cancer od Myers, Andrea P., Konstantinopoulos, Panagiotis A., Barry, William T., Luo, Weixiu, Broaddus, Russell R., Makker, Vicky, Drapkin, Ronny, Liu, Joyce, Doyle, Austin, Horowitz, Neil S., Meric-Bernstam, Funda, Birrer, Michael, Aghajanian, Carol, Coleman, Robert L., Mills, Gordon B., Cantley, Lewis C., Matulonis, Ursula A., Westin, Shannon N.

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory B-cell Neoplasms od Holkova, Beata, Perkins, E. Brent, Ramakrishnan, Viswanathan, Tombes, Mary Beth, Shrader, Ellen, Talreja, Neha, Wellons, Martha D., Hogan, Kevin T., Roodman, G. David, Coppola, Domenico, Kang, Loveleen, Dawson, Jana, Stuart, Robert K., Peer, Cody, Figg, William D., Kolla, Sarah, Doyle, Austin, Wright, John, Sullivan, Daniel M., Roberts, John D., Grant, Steven

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial od Lopez-Chavez, Ariel, Thomas, Anish, Rajan, Arun, Raffeld, Mark, Morrow, Betsy, Kelly, Ronan, Carter, Corey Allan, Guha, Udayan, Killian, Keith, Lau, Christopher C., Abdullaev, Zied, Xi, Liqiang, Pack, Svetlana, Meltzer, Paul S., Corless, Christopher L., Sandler, Alan, Beadling, Carol, Warrick, Andrea, Liewehr, David J., Steinberg, Seth M., Berman, Arlene, Doyle, Austin, Szabo, Eva, Wang, Yisong, Giaccone, Giuseppe

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas od Dombi, Eva, Baldwin, Andrea, Marcus, Leigh J., Fisher, Michael J., Weiss, Brian, Kim, AeRang, Whitcomb, Patricia, Martin, Staci, Aschbacher-Smith, Lindsey E., Rizvi, Tilat A., Wu, Jianqiang, Ershler, Rachel, Wolters, Pamela, Therrien, Janet, Glod, John, Belasco, Jean B., Schorry, Elizabeth, Brofferio, Alessandra, Starosta, Amy J., Gillespie, Andrea, Doyle, Austin L., Ratner, Nancy, Widemann, Brigitte C.

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

A Phase 2 Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma od Holkova, Beata, Zingone, Adriana, Kmieciak, Maciej, Bose, Prithviraj, Badros, Ashraf Z., Voorhees, Peter M., Baz, Rachid, Korde, Neha, Lin, Hui-Yi, Chen, Jin-Qiu, Herrmann, Michelle, Xi, Liqiang, Raffeld, Mark, Zhao, Xiuhua, Wan, Wen, Tombes, Mary Beth, Shrader, Ellen, Weir-Wiggins, Caryn, Sankala, Heidi, Hogan, Kevin T., Doyle, Austin, Annunziata, Christina M., Wellons, Martha, Roberts, John D., Sullivan, Daniel, Landgren, Ola, Grant, Steven

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Relationship between Physician-Adjudicated Adverse Events and Patient-Reported Health-Related Quality of Life in a Phase II Clinical Trial (NCT01143402) of Patients with Metastatic... od Atkinson, Thomas M., Hay, Jennifer L., Shoushtari, Alexander, Li, Yuelin, Paucar, Daniel J., Smith, Sloane C., Kudchadkar, Ragini R., Doyle, Austin, Sosman, Jeffrey A., Quevedo, Jorge Fernando, Milhem, Mohammed M., Joshua, Anthony M., Linette, Gerald P., Gajewski, Thomas F., Lutzky, Jose, Lawson, David H., Lao, Christopher D., Flynn, Patrick J., Albertini, Mark R., Sato, Takami, Lewis, Karl, Marr, Brian, Abramson, David H., Dickson, Mark Andrew, Schwartz, Gary K., Carvajal, Richard D.

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Effect of Selumetinib versus Chemotherapy on Progression-Free Survival in Uveal Melanoma: A Randomized Clinical Trial od Carvajal, Richard D., Sosman, Jeffrey A., Quevedo, Jorge Fernando, Milhem, Mohammed M., Joshua, Anthony Michael, Kudchadkar, Ragini R., Linette, Gerald P., Gajewski, Thomas F., Lutzky, Jose, Lawson, David H., Lao, Christopher D., Flynn, Patrick J., Albertini, Mark R., Sato, Takami, Lewis, Karl, Doyle, Austin, Ancell, Kristin, Panageas, Katherine S., Bluth, Mark, Hedvat, Cyrus, Erinjeri, Joseph, Ambrosini, Grazia, Marr, Brian, Abramson, David, Dickson, Mark Andrew, Wolchok, Jedd D., Chapman, Paul B., Schwartz, Gary K.

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND... od Fangusaro, Jason, Onar-Thomas, Arzu, Poussaint, Tina Young, Wu, Shengjie, Ligon, Azra H, Lindeman, Neal, Banerjee, Anu, Packer, Roger J, Kilburn, Lindsay B, Goldman, Stewart, Pollack, Ian F, Jakacki, Regina I, Qaddoumi, Ibrahim, Fisher, Paul G, Dhall, Girish, Baxter, Patricia, Kreissman, Susa G, Stewart, Clinton F, Jones, David T W, Pfister, Stefan M, Vezina, Gilbert, Stern, Jessica S, Panigrahy, Ashok, Jones, Blaise V, Patay, Zoltan, Tamrazi, Benita, Jones, Jeremy Y, Haque, Sofia S, Enterline, David S, Cha, Soonme, Fisher, Michael J, Doyle, Austin, Smith, Malcolm, Fouladi, Maryam, Dunkel, Ira J

Preuzmi cijeli tekst Preuzmi cijeli tekst